news
Understanding Your Risk: A Guide to Breast Cancer Recurrence Testing
Download the complete transcript.
If you or someone you love has been diagnosed with breast cancer, you may have heard terms like Prosigna, TrueMRD, Oncotype, MammaPrint, and Precise – but what do these tests actually mean, and how do they help guide treatment decisions?
Join Sharsheret for Part 1 of our two-part webinar series on risk of recurrence, where Dr. Noam Drazin, MD will walk us through the landscape of genomic and recurrence risk testing: what each test measures, how results are used, and what questions to ask your medical team.
With support from:
One-on-one support
Contact our clinical team of trained, skilled mental health professionals and genetic counselors to speak privately at any point in the cancer journey.
Peer-to-peer support
Connecting with someone who has walked a similar path can provide emotional reassurance, practical advice, and true understanding.
Stay connected
Our emails include Sharsheret news, support, upcoming webinars, and events.